COM:SPRINGWORKSTX

SpringWorks Therapeutics

Stock

USD

Last Close

36.30

22/11 21:00

Market Cap

2.93B

Beta: -

Volume Today

1.41M

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-17.81M -	-58.31M 227.32%	-45.57M 21.84%	-173.91M 281.60%	-277.42M 59.52%	-325.10M 17.19%
depreciation and amortization	17K -	192K 1,029.41%	349K 81.77%	490K 40.40%	765K 56.12%	1.67M 117.91%
deferred income tax			605K -	988K 63.31%		9.23M -
stock based compensation	1.07M -	3.11M 190.83%	10.03M 222.74%	38.44M 283.14%	72.97M 89.80%	94.53M 29.56%
change in working capital	2.02M -	4.95M 144.78%	1.35M 72.79%	5.12M 280.24%	38.10M 644.49%	-583K 101.53%
accounts receivables						-5.93M -
inventory						-3.10M -
accounts payables	491K -	1.88M 282.89%	-1.30M 169.36%	2.07M 259.05%	4.17M 100.96%	-196K 104.70%
other working capital	1.53M -	3.07M 100.46%	2.65M 13.60%	3.04M 14.87%	33.94M 1,014.82%	9.23M 72.80%
other non cash items		2.61M -	1.05M 59.87%	993K 5.34%	4.02M 304.93%	-2.54M 163.12%
net cash provided by operating activities	-14.71M -	-47.44M 222.62%	-32.19M 32.15%	-127.88M 297.24%	-161.56M 26.34%	-222.79M 37.90%
investments in property plant and equipment	-293K -	-670K 128.67%	-642K 4.18%	-2.02M 214.02%	-10.20M 405.75%	-7.38M 27.57%
acquisitions net		-3.59M -	-3.50M 2.51%	2.02M 157.60%	-4.20M 308.33%	-2.80M 33.33%
purchases of investments		-3.59M -	-442.69M 12,231.20%	-305.42M 31.01%	-481.05M 57.50%	-575.72M 19.68%
sales maturities of investments		3.59M -	28M 679.17%	391.03M 1,296.54%	279.85M 28.43%	620.66M 121.78%
other investing activites		-3.59K -		-2.02M -
net cash used for investing activites	-293K -	-4.26M 1,353.92%	-418.83M 9,731.74%	83.59M 119.96%	-215.60M 357.92%	34.75M 116.12%
debt repayment
common stock issued		169.73M -	269.59M 58.84%	1.16M 99.57%	340.07M 29,292.05%	299.30M 11.99%
common stock repurchased					-1.34M -	-2.80M 108.80%
dividends paid
other financing activites	50.38M -	163.98M 225.51%	893K 99.46%		1.98M -	139K 92.97%
net cash used provided by financing activities	50.38M -	333.71M 562.43%	270.49M 18.95%	1.16M 99.57%	340.70M 29,347.02%	296.64M 12.93%
effect of forex changes on cash
net change in cash	35.38M -	282.00M 697.14%	-180.54M 164.02%	-43.13M 76.11%	-36.46M 15.47%	108.60M 397.87%
cash at beginning of period	10.27M -	46.19M 349.69%	328.19M 610.56%	147.65M 55.01%	104.53M 29.21%	68.07M 34.88%
cash at end of period	45.65M -	328.19M 618.96%	147.65M 55.01%	104.53M 29.21%	68.07M 34.88%	176.67M 159.54%
operating cash flow	-14.71M -	-47.44M 222.62%	-32.19M 32.15%	-127.88M 297.24%	-161.56M 26.34%	-222.79M 37.90%
capital expenditure	-293K -	-670K 128.67%	-642K 4.18%	-2.02M 214.02%	-10.20M 405.75%	-7.38M 27.57%
free cash flow	-15.00M -	-48.11M 220.78%	-32.83M 31.76%	-129.89M 295.62%	-171.76M 32.23%	-230.18M 34.01%

All numbers in USD (except ratios and percentages)